| Th17 cell, the new player of neuroinflammatory process in multiple sclerosis F Jadidi‐Niaragh, A Mirshafiey Scandinavian journal of immunology 74 (1), 1-13, 2011 | 543 | 2011 |
| Randomized controlled trial using vitamins E and D supplementation in atopic dermatitis MH Javanbakht, SA Keshavarz, M Djalali, F Siassi, MR Eshraghian, ... Journal of dermatological treatment 22 (3), 144-150, 2011 | 217 | 2011 |
| Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis G Azizi, F Jadidi‐Niaragh, A Mirshafiey International journal of rheumatic diseases 16 (3), 243-253, 2013 | 163 | 2013 |
| Prostaglandins and rheumatoid arthritis MJ Fattahi, A Mirshafiey Arthritis 2012, 2012 | 129 | 2012 |
| Antioxidant therapy in multiple sclerosis A Mirshafiey, M Mohsenzadegan Immunopharmacology and Immunotoxicology 31 (1), 13-29, 2009 | 122 | 2009 |
| Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis F Jadidi-Niaragh, A Mirshafiey Neuropharmacology 59 (3), 180-189, 2010 | 118 | 2010 |
| The role of different subsets of regulatory T cells in immunopathogenesis of rheumatoid arthritis M Gol-Ara, F Jadidi-Niaragh, R Sadria, G Azizi, A Mirshafiey Arthritis 2012, 2012 | 115 | 2012 |
| Venom therapy in multiple sclerosis A Mirshafiey Neuropharmacology 53 (3), 353-361, 2007 | 108 | 2007 |
| The immunopathogenic role of reactive oxygen species in Alzheimer disease M Mohsenzadegan, A Mirshafiey Iranian Journal of Allergy, Asthma and Immunology, 203-216, 2012 | 105 | 2012 |
| T-cell abnormalities in common variable immunodeficiency. G Azizi, N Rezaei, F Kiaee, N Tavakolinia, R Yazdani, A Mirshafiey, ... Journal of investigational allergology & clinical immunology 26 (4), 233-43, 2016 | 91 | 2016 |
| The potential role of chemokines in Alzheimer’s disease pathogenesis G Azizi, N Khannazer, A Mirshafiey American Journal of Alzheimer's Disease & Other Dementias® 29 (5), 415-425, 2014 | 88 | 2014 |
| The potential role of proinflammatory and antiinflammatory cytokines in Alzheimer disease pathogenesis G Azizi, A Mirshafiey Immunopharmacology and immunotoxicology 34 (6), 881-895, 2012 | 88 | 2012 |
| TGF-β as a promising option in the treatment of multiple sclerosis A Mirshafiey, M Mohsenzadegan Neuropharmacology 56 (6-7), 929-936, 2009 | 87 | 2009 |
| The significance of matrix metalloproteinases in the immunopathogenesis and treatment of multiple sclerosis A Mirshafiey, B Asghari, G Ghalamfarsa, F Jadidi-Niaragh, G Azizi Sultan Qaboos University Medical Journal 14 (1), e13, 2014 | 86 | 2014 |
| The role of inflammatory mediators in the pathogenesis of Alzheimer’s disease G Azizi, SS Navabi, A Al-Shukaili, MH Seyedzadeh, R Yazdani, ... Sultan Qaboos University Medical Journal 15 (3), e305, 2015 | 81 | 2015 |
| Anti‐citrullinated protein antibodies and their clinical utility in rheumatoid arthritis SS Farid, G Azizi, A Mirshafiey International journal of rheumatic diseases 16 (4), 379-386, 2013 | 79 | 2013 |
| Th22 cells in autoimmunity: a review of current knowledge. G Azizi, R Yazdani, A Mirshafiey European annals of allergy and clinical immunology 47 (4), 108-117, 2015 | 78 | 2015 |
| Does lipoic acid consumption affect the cytokine profile in multiple sclerosis patients: a double-blind, placebo-controlled, randomized clinical trial M Khalili, A Azimi, V Izadi, S Eghtesadi, A Mirshafiey, MA Sahraian, ... Neuroimmunomodulation 21 (6), 291-296, 2014 | 78 | 2014 |
| Novel immunosuppressive therapy by M2000 in experimental multiple sclerosis A Mirshafiey, H Matsuo, S Nakane, BHA Rehm, CS Koh, S Miyoshi Immunopharmacology and immunotoxicology 27 (2), 255-265, 2005 | 77 | 2005 |
| The deviated balance between regulatory T cell and Th17 in autoimmunity F Jadidi-Niaragh, A Mirshafiey Immunopharmacology and immunotoxicology 34 (5), 727-739, 2012 | 71 | 2012 |
